National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Location status: Recruiting
NCT Number: NCT02821767
Background:
The National Eye Institute (NEI) wants to evaluate and provide standard treatment to people with eye diseases.
Objective:
To examine and treat people with eye diseases and learn more about eye diseases and how they are inherited.
Eligibility:
People with eye diseases who can give consent or have a guardian who can consent for them. Asymptomatic first-degree relatives willing to provide a blood sample may also be enrolled for the purpose of genetic testing.
Design:
Participants will be screened with an eye exam.
Participants will have 1-12 visits per year depending on their eye disease for up to 5 years. Visits last about 4 hours and could include:
Medical and family history
Physical exam
Eye exam and photography.
Oculography: They put on contact lenses or goggles. They watch spots on a computer screen for 20-30 minutes.
Electrooculography: Small metal disks are placed on the skin next to both eyes. They look left
and right in the dark and light for about 30 minutes.
Electroretinography: They sit in the dark with their eyes patched. A small metal disk is taped
to the forehead. After 30 minutes, the patches are removed and contact lenses put in. They
watch flashing lights.
Fluorescein angiography: A needle guides a thin plastic tube into an arm vein. A dye is
injected through the tube and travels up the blood vessels in the eyes. Pictures are taken of the eyes.
Immunosuppressive treatment
Eye cell sample: Samples are obtained from swabbing, pressing paper on, or taking a small
biopsy sample from the surface of the eye.
Blood tests
Skin, tear, urine, saliva, stool, or hair sample
Exam under anesthesia for some children
At each visit participants could get medications, eye drops, eye injections, laser treatments, or surgery.
Interested in participating?
Request Info2 year–100 year
All sexes
Observational
Bethesda, Maryland, 20892, United States
Location status: Recruiting
The National Eye Institute (NEI) is conducting a study to evaluate and provide standard treatment to participants with various diagnosed and undiagnosed ocular conditions.
Objective: The primary objective of this protocol is to collect data and specimens generated
through clinical care procedures. Through this primary objective, the secondary objectives (establish a resource of patients with ocular conditions to facilitate recruitment into new research protocols at the NEI, gain additional knowledge about the course of specific ocular diseases and characterize the natural history of such diseases (to generate hypotheses for future clinical research studies), and evaluate the effects of standard of care treatments) may be achieved.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
To be eligible, the following inclusion criteria must be met, where applicable.
Exclusion criteria
A participant is not eligible if any of the following exclusion criteria are present.
Time frame: ongoing
response to standard care of treatment
Interested in participating?
Request InfoNational Eye Institute (NEI)
Nih
Studies of the Natural History, Pathogenesis and Outcome of Ocular Disorders
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06771908
Conjunctival Diseases, Conjunctivitis
Rome, Italy
View Trial DetailsNCT07401459
AI Agent, Eye Disease
Hong Kong, China
View Trial DetailsNCT00386906
Eye Disease, Eye Diseases
Houston, Texas, United States
View Trial DetailsNCT06822023
Anxiety Disorders, Cataract Surgery
View Trial Details